4//SEC Filing
Larkin Cristina 4
Accession 0000899243-20-002616
CIK 0001701108other
Filed
Feb 2, 7:00 PM ET
Accepted
Feb 3, 5:32 PM ET
Size
5.6 KB
Accession
0000899243-20-002616
Insider Transaction Report
Form 4
Larkin Cristina
Chief Operating Officer
Transactions
- Award
Stock Option (Right to Buy)
2020-02-03+55,000→ 55,000 totalExercise: $9.34Exp: 2030-02-03→ Common Stock (55,000 underlying)
Footnotes (1)
- [F1]The shares underlying this option vest as to 25% on February 3, 2021, with the remainder vesting in 36 equal monthly installments thereafter, subject to the Reporting Person's continued service through the applicable vesting date.
Documents
Issuer
Spero Therapeutics, Inc.
CIK 0001701108
Entity typeother
Related Parties
1- filerCIK 0001721173
Filing Metadata
- Form type
- 4
- Filed
- Feb 2, 7:00 PM ET
- Accepted
- Feb 3, 5:32 PM ET
- Size
- 5.6 KB